FAM20A Deficiency Drives Transcriptomic Dysregulation and Functional Impairment in Gingival Fibroblasts

Abstract

Amelogenesis imperfecta type 1G (AI1G), also known as Enamel-Renal-Gingival Syndrome (ERGS), is an autosomal recessive disorder caused by variants in FAM20A, encoding a Golgi apparatus protein crucial for protein processing and secretion. AI1G presents with enamel defects, nephrocalcinosis and gingival overgrowth. Building upon our previous findings demonstrating the impact of FAM20A insufficiency on deciduous dental pulp cells, this study investigated the molecular mechanisms underlying gingival fibromatosis in AI1G. RNA sequencing of gingival fibroblasts from an AI1G patient revealed widespread differential gene expression (DEG). Gene Ontology (GO) analysis demonstrated enrichment of DEGs in biological processes related to cell adhesion, differentiation, proliferation (including positive regulation and cell division), cell cycle regulation, apoptosis and signal transduction. Pathway analysis (Reactome and KEGG) further highlighted the dysregulation of signalling pathways, including Wnt, TGF-β, cell cycle, DNA replication, Rho GTPase signalling and extracellular matrix organisation. Functional assays confirmed these findings, revealing delayed initial attachment and spreading, impaired osteogenic differentiation (evidenced by reduced mineralization and downregulation of DLX5, OCN, RUNX2 and OPN), enhanced cell cycle progression and proliferation (increased colony size and proliferation rates, along with a shift from G0/G1 to G2/M phase) and suppressed apoptosis in FAM20A-insufficient fibroblasts. These results suggest that FAM20A plays a critical role in regulating fundamental processes in gingival fibroblasts, and its insufficiency contributes to the gingival fibromatosis phenotype observed in AI1G through the disruption of cell adhesion, differentiation, proliferation and apoptosis. This study proposes novel insights into the pathogenesis of AI1G and highlights potential therapeutic targets for this complex disorder.

Keywords

diagnosis / healthcare / renal stones / stem cells / therapy / tooth eruption

References

[1] A. Bloch-Zupan, T. Rey, A. Jimenez-Armijo, et al., “Amelogenesis Imperfecta: Next-Generation Sequencing Sheds Light on Witkop's Classification,” Frontiers in Physiology 14 (2023): 1130175, https://doi.org/10.3389/fphys.2023.1130175.

[2] K. Sriwattanapong, I. Nitayavardhana, T. Theerapanon, et al., “Age-Related Dental Phenotypes and Tooth Characteristics of FAM83H-Associated Hypocalcified Amelogenesis Imperfecta,” Oral Diseases 28, no. 3 (2022): 734–744, https://doi.org/10.1111/odi.13780.

[3] G. Lignon, F. Beres, M. Quentric, et al., “FAM20A Gene Mutation: Amelogenesis or Ectopic Mineralization?,” Frontiers in Physiology 8 (2017): 267, https://doi.org/10.3389/fphys.2017.00267.

[4] M. Volodarsky, U. Zilberman, and O. S. Birk, “Novel FAM20A Mutation Causes Autosomal Recessive Amelogenesis Imperfecta,” Archives of Oral Biology 60, no. 6 (2015): 919–922, https://doi.org/10.1016/j.archoralbio.2015.02.018.

[5] I. Nitayavardhana, T. Theerapanon, C. Srichomthong, et al., “Four Novel Mutations of FAM20A in Amelogenesis Imperfecta Type IG and Review of Literature for Its Genotype and Phenotype Spectra,” Molecular Genetics and Genomics 295 (2020): 923–931, https://doi.org/10.1007/s00438-020-01668-8.

[6] K. Sriwattanapong, T. Theerapanon, C. Khamwachirapitak, et al., “Authors’ Reply to: Deep Dental Phenotyping and A Novel FAM20A Variant in Patients with Amelogenesis Imperfecta Type IG,” Oral Diseases 30, no. 5 (2023): 3533–3535, https://doi.org/10.1111/odi.14765.

[7] J. O'Sullivan, C. Bitu Carolina, B. Daly Sarah, et al., “Whole-Exome Sequencing Identifies FAM20A Mutations as a Cause of Amelogenesis Imperfecta and Gingival Hyperplasia Syndrome,” American Journal of Human Genetics 88, no. 5 (2011): 616–620, https://doi.org/10.1016/j.ajhg.2011.04.005.

[8] K. Sriwattanapong, T. Theerapanon, C. Khamwachirapitak, et al., “In-Depth Investigation of FAM20A Insufficiency Effects on Deciduous Dental Pulp Cells: Altered Behaviours, Osteogenic Differentiation, and Inflammatory Gene Expression,” International Endodontic Journal 57, no. 6 (2024): 745–758, https://doi.org/10.1111/iej.14056.

[9] V. Simancas Escorcia, C. Guillou, L. Abbad, et al., “Pathogenesis of Enamel-Renal Syndrome Associated Gingival Fibromatosis: A Proteomic Approach,” Frontiers in Endocrinology 12 (2021): 752568, https://doi.org/10.3389/fendo.2021.752568.

[10] Y. P. Wang, H. Y. Lin, W. L. Zhong, J. P. Simmer, and S. K. Wang, “Transcriptome Analysis of Gingival Tissues of Enamel-Renal Syndrome,” Journal of Periodontal Research 54, no. 6 (2019): 653–661, https://doi.org/10.1111/jre.12666.

[11] K. Sriwattanapong, T. Theerapanon, C. Khamwachirapitak, et al., “Deep Dental Phenotyping and a Novel FAM20A Variant in Patients With Amelogenesis Imperfecta Type IG,” Oral Diseases 30, no. 2 (2024): 537–550, https://doi.org/10.1111/odi.14510.

[12] V. Simancas Escorcia, A. Diarra, A. Naveau, et al., “Lack of FAM20A, Ectopic Gingival Mineralization and Chondro/Osteogenic Modifications in Enamel Renal Syndrome,” Frontiers in Cell and Developmental Biology 8 (2020): 605084, https://doi.org/10.3389/fcell.2020.605084.

[13] S. K. Wang, H. Zhang, Y. L. Wang, et al., “FAM20A Mutations and Transcriptome Analyses of Dental Pulp Tissues of Enamel Renal Syndrome,” International Endodontic Journal 56, no. 8 (2023): 943–954, https://doi.org/10.1111/iej.13928.

[14] T. Faruangsaeng, S. Thaweesapphitak, C. Khamwachirapitak, T. Porntaveetus, and V. Shotelersuk, “Comparative Transcriptome Profiles of Human Dental Pulp Stem Cells From Maxillary and Mandibular Teeth,” Scientific Reports 12, no. 1 (2022): 8860, https://doi.org/10.1038/s41598-022-12867-1.

[15] N. Nowwarote, T. Theerapanon, T. Osathanon, P. Pavasant, T. Porntaveetus, and V. Shotelersuk, “Amelogenesis Imperfecta: A Novel FAM83H Mutation and Characteristics of Periodontal Ligament Cells,” Oral Diseases 24, no. 8 (2018): 1522–1531, https://doi.org/10.1111/odi.12926.

[16] T. Porntaveetus, N. Nowwarote, T. Osathanon, et al., “Compromised Alveolar Bone Cells in a Patient With Dentinogenesis Imperfecta Caused by DSPP Mutation,” Clinical Oral Investigations 23, no. 1 (2019): 303–313, https://doi.org/10.1007/s00784-018-2437-7.

[17] X. Chen, J. Huang, J. Wu, et al., “Human Mesenchymal Stem Cells,” Cell Proliferation 55, no. 4 (2022): e13141, https://doi.org/10.1111/cpr.13141.

[18] A. I. Bachir, A. R. Horwitz, W. J. Nelson, and J. M. Bianchini, “Actin-Based Adhesion Modules Mediate Cell Interactions With the Extracellular Matrix and Neighboring Cells,” Cold Spring Harbor Perspectives in Biology 9, no. 7 (2017): a023234, https://doi.org/10.1101/cshperspect.a023234.

[19] C. Di Ciano-Oliveira, A. C. Thirone, K. Szászi, and A. Kapus, “Osmotic Stress and the Cytoskeleton: The R(h)ole of Rho GTPases,” Acta Physiologica 187, no. 1–2 (2006): 257–272, https://doi.org/10.1111/j.1748-1716.2006.01535.x.

[20] T. N. Wight and S. Potter-Perigo, “The Extracellular Matrix: An Active or Passive Player in Fibrosis?,” American Journal of Physiology. Gastrointestinal and Liver Physiology 301, no. 6 (2011): G950–G955, https://doi.org/10.1152/ajpgi.00132.2011.

[21] D. A. Tipton, K. J. Howell, and M. K. Dabbous, “Increased Proliferation, Collagen, and Fibronectin Production by Hereditary Gingival Fibromatosis Fibroblasts,” Journal of Periodontology 68, no. 6 (1997): 524–530, https://doi.org/10.1902/jop.1997.68.6.524.

[22] D. A. Calderwood, S. J. Shattil, and M. H. Ginsberg, “Integrins and Actin Filaments: Reciprocal Regulation of Cell Adhesion and Signaling*,” Journal of Biological Chemistry 275, no. 30 (2000): 22607–22610, https://doi.org/10.1074/jbc.R900037199.

[23] Q. Hu, K. Saleem, J. Pandey, A. N. Charania, Y. Zhou, and C. He, “Cell Adhesion Molecules in Fibrotic Diseases,” Biomedicine 11, no. 7 (2023): 1995, https://doi.org/10.3390/biomedicines11071995.

[24] C. Niu, Y. Hu, K. Xu, X. Pan, L. Wang, and G. Yu, “The Role of the Cytoskeleton in Fibrotic Diseases,” Frontiers in Cell and Developmental Biology 12 (2024): 1490315, https://doi.org/10.3389/fcell.2024.1490315.

[25] J. Silvestre, P. J. Kenis, and D. E. Leckband, “Cadherin and Integrin Regulation of Epithelial Cell Migration,” Langmuir 25, no. 17 (2009): 10092–10099, https://doi.org/10.1021/la901109e.

[26] M. R. Chastney, J. Kaivola, V.-M. Leppänen, and J. Ivaska, “The Role and Regulation of Integrins in Cell Migration and Invasion,” Nature Reviews Molecular Cell Biology 26 (2024): 147–167, https://doi.org/10.1038/s41580-024-00777-1.

[27] H. Júnior, C. Santos, P. Bonan, et al., “Minichromosome Maintenance 2 and 5 Expressions Are Increased in the Epithelium of Hereditary Gingival Fibromatosis Associated With Dental Abnormalities,” Clinics (São Paulo, Brazil) 66 (2011): 753–757, https://doi.org/10.1590/S1807-59322011000500008.

[28] R. G. Carreón-Burciaga, R. González-González, N. Molina-Frechero, and R. Bologna-Molina, “Immunoexpression of Ki-67, MCM2, and MCM3 in Ameloblastoma and Ameloblastic Carcinoma and Their Correlations With Clinical and Histopathological Patterns,” Disease Markers 2015 (2015): 683087, https://doi.org/10.1155/2015/683087.

[29] O. Rath and F. Kozielski, “Kinesins and Cancer,” Nature Reviews. Cancer 12, no. 8 (2012): 527–539, https://doi.org/10.1038/nrc3310.

[30] J. Chen, X. Xu, S. Chen, et al., “Double Heterozygous Pathogenic Mutations in KIF3C and ZNF513 Cause Hereditary Gingival Fibromatosis,” International Journal of Oral Science 15, no. 1 (2023): 46, https://doi.org/10.1038/s41368-023-00244-1.

[31] M. Risteli, H. Ruotsalainen, A. Salo, et al., “Reduction of Lysyl Hydroxylase 3 Causes Deleterious Changes in the Deposition and Organization of Extracellular Matrix,” Journal of Biological Chemistry 284 (2009): 28204–28211, https://doi.org/10.1074/jbc.M109.038190.

[32] H. Martelli-Júnior, P. R. Bonan, L. A. Dos Santos, S. M. Santos, M. G. Cavalcanti, and R. D. Coletta, “Case Reports of a New Syndrome Associating Gingival Fibromatosis and Dental Abnormalities in a Consanguineous Family,” Journal of Periodontology 79, no. 7 (2008): 1287–1296, https://doi.org/10.1902/jop.2008.070520.

[33] D. Spiering and L. Hodgson, “Dynamics of the Rho-Family Small GTPases in Actin Regulation and Motility,” Cell Adhesion & Migration 5, no. 2 (2011): 170–180, https://doi.org/10.4161/cam.5.2.14403.

[34] S. Kobayashi-Kinoshita, Y. Yamakoshi, K. Onuma, R. Yamamoto, and Y. Asada, “TGF-β1 Autocrine Signalling and Enamel Matrix Components,” Scientific Reports 6 (2016): 33644, https://doi.org/10.1038/srep33644.

[35] M. Huckert, C. Stoetzel, S. Morkmued, et al., “Mutations in the Latent TGF-Beta Binding Protein 3 (LTBP3) Gene Cause Brachyolmia With Amelogenesis Imperfecta,” Human Molecular Genetics 24, no. 11 (2015): 3038–3049, https://doi.org/10.1093/hmg/ddv053.

[36] N. Frangogiannis, “Transforming Growth Factor-β in Tissue Fibrosis,” Journal of Experimental Medicine 217, no. 3 (2020): e20190103, https://doi.org/10.1084/jem.20190103.

[37] E. Matalová, V. Lungova, and P. Sharpe, “ Development of Tooth and Associated Structures,” in Stem Cell Biology and Tissue Engineering in Dental Sciences (Elsevier, 2015), 335–346, https://doi.org/10.1016/B978-0-12-397157-9.00030-8.

[38] M. Wu, G. Chen, and Y.-P. Li, “TGF-β and BMP Signaling in Osteoblast, Skeletal Development, and Bone Formation, Homeostasis and Disease,” Bone Research 4, no. 1 (2016): 16009, https://doi.org/10.1038/boneres.2016.9.

[39] C. Galada, H. Shah, A. Shukla, and K. M. Girisha, “A Novel Sequence Variant in SFRP4 Causing Pyle Disease,” Journal of Human Genetics 62, no. 5 (2017): 575–576, https://doi.org/10.1038/jhg.2016.166.

[40] K. Miyama, G. Yamada, T. S. Yamamoto, et al., “A BMP-Inducible Gene, dlx5, Regulates Osteoblast Differentiation and Mesoderm Induction,” Developmental Biology 208, no. 1 (1999): 123–133, https://doi.org/10.1006/dbio.1998.9197.

[41] M. H. Lee, Y. J. Kim, H. J. Kim, et al., “BMP-2-Induced Runx2 Expression Is Mediated by Dlx5, and TGF-Beta 1 Opposes the BMP-2-Induced Osteoblast Differentiation by Suppression of Dlx5 Expression,” Journal of Biological Chemistry 278, no. 36 (2003): 34387–34394, https://doi.org/10.1074/jbc.M211386200.

[42] J. Liu, K. Saito, Y. Maruya, et al., “Mutant GDF5 Enhances Ameloblast Differentiation via Accelerated BMP2-Induced Smad1/5/8 Phosphorylation,” Scientific Reports 6, no. 1 (2016): 23670, https://doi.org/10.1038/srep23670.

[43] A. Rakian, W. C. Yang, J. Gluhak-Heinrich, et al., “Bone Morphogenetic Protein-2 Gene Controls Tooth Root Development in Coordination With Formation of the Periodontium,” International Journal of Oral Science 5, no. 2 (2013): 75–84, https://doi.org/10.1038/ijos.2013.41.

[44] L. Li, W. Saiyin, H. Zhang, et al., “FAM20A is Essential for Amelogenesis, but is Dispensable for Dentinogenesis,” Journal of Molecular Histology 50 (2019): 1–591, https://doi.org/10.1007/s10735-019-09851-x.

[45] J. Cui, J. Xiao, V. S. Tagliabracci, J. Wen, M. Rahdar, and J. E. Dixon, “A Secretory Kinase Complex Regulates Extracellular Protein Phosphorylation,” eLife 4 (2015): e06120, https://doi.org/10.7554/eLife.06120.

[46] M. Wu, S. Wu, W. Chen, and Y.-P. Li, “The Roles and Regulatory Mechanisms of TGF-β and BMP Signaling in Bone and Cartilage Development, Homeostasis and Disease,” Cell Research 34, no. 2 (2024): 101–123, https://doi.org/10.1038/s41422-023-00918-9.

RIGHTS & PERMISSIONS

2025 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.